Revisiting Disrupted-In-Schizophrenia 1 As a Scaffold Protein
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated. -
DISC1 a Key Molecular Lead in Psychiatry and Neurodevelopment: No-More Disrupted-In-Schizophrenia 1
Molecular Psychiatry (2016) 21, 1488–1489 © 2016 Macmillan Publishers Limited, part of Springer Nature. All rights reserved 1359-4184/16 www.nature.com/mp NEWS AND COMMENTARY DISC1 a key molecular lead in psychiatry and neurodevelopment: No-More Disrupted-in-Schizophrenia 1 M Niwa1, T Cash-Padgett1,4, K-I Kubo2,4, A Saito1,4, K Ishii1,4, A Sumitomo3, Y Taniguchi1, K Ishizuka1, H Jaaro-Peled1, T Tomoda3, K Nakajima2, A Sawa1 and A Kamiya1 Molecular Psychiatry (2016) 21, 1488–1489; doi:10.1038/ second, although DISC1 is a multifunctional intracellular hub mp.2016.154; published online 6 September 2016 protein, we still do not know which specific function of DISC1 underlies each endophenotype or phenotype in mental conditions. Since the middle of the past century, we have serendipitously To address the first question on genetic validity, Sullivan7 come across treatment regimens that can partially ameliorate pointed out that DISC1 is unlikely to be an important ‘genetic’ psychosis and depression. Nonetheless, the mechanisms under- factor for schizophrenia defined by the Diagnostic and Statistical lying such severe mental conditions still remain elusive. Such lack Manual of Mental Disorders (DSM). This discussion is fairly valid, of mechanistic insight into major mental illnesses has hampered and we agree with this statement and conclude as ‘No-More the establishment of precise diagnostic framework, precluding Disrupted-in-Schizophrenia 1.’ Regarding the second question, Tsuboi further discovery of fundamental treatments for these disorders. et al.8 have recently encouraged the field to reinforce the evidence Meanwhile, understanding of the brain at the molecular level that supports the role for DISC1 in early development. -
The TRAX, DISC1, and GSK3 Complex in Mental Disorders and Therapeutic Interventions Yu-Ting Weng1,2, Ting Chien1, I-I Kuan1 and Yijuang Chern1,2*
Weng et al. Journal of Biomedical Science (2018) 25:71 https://doi.org/10.1186/s12929-018-0473-x REVIEW Open Access The TRAX, DISC1, and GSK3 complex in mental disorders and therapeutic interventions Yu-Ting Weng1,2, Ting Chien1, I-I Kuan1 and Yijuang Chern1,2* Abstract Psychiatric disorders (such as bipolar disorder, depression, and schizophrenia) affect the lives of millions of individuals worldwide. Despite the tremendous efforts devoted to various types of psychiatric studies and rapidly accumulating genetic information, the molecular mechanisms underlying psychiatric disorder development remain elusive. Among the genes that have been implicated in schizophrenia and other mental disorders, disrupted in schizophrenia 1 (DISC1) and glycogen synthase kinase 3 (GSK3) have been intensively investigated. DISC1 binds directly to GSK3 and modulates many cellular functions by negatively inhibiting GSK3 activity. The human DISC1 gene is located on chromosome 1 and is highly associated with schizophrenia and other mental disorders. A recent study demonstrated that a neighboring gene of DISC1, translin-associated factor X (TRAX), binds to the DISC1/GSK3β complex and at least partly mediates the actions of the DISC1/GSK3β complex. Previous studies also demonstrate that TRAX and most of its interacting proteins that have been identified so far are risk genes and/or markers of mental disorders. In the present review, we will focus on the emerging roles of TRAX and its interacting proteins (including DISC1 and GSK3β) in psychiatric disorders and the potential implications for developing therapeutic interventions. Keywords: TRAX, DISC1, GSK3β, Mental disorders, DNA damage, DNA repair, Oxidative stress, A2AR, PKA Background DNA repair) by interacting with various proteins [4–12]. -
Convergent Functional Genomics of Schizophrenia: from Comprehensive Understanding to Genetic Risk Prediction
Molecular Psychiatry (2012) 17, 887 -- 905 & 2012 Macmillan Publishers Limited All rights reserved 1359-4184/12 www.nature.com/mp IMMEDIATE COMMUNICATION Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction M Ayalew1,2,9, H Le-Niculescu1,9, DF Levey1, N Jain1, B Changala1, SD Patel1, E Winiger1, A Breier1, A Shekhar1, R Amdur3, D Koller4, JI Nurnberger1, A Corvin5, M Geyer6, MT Tsuang6, D Salomon7, NJ Schork7, AH Fanous3, MC O’Donovan8 and AB Niculescu1,2 We have used a translational convergent functional genomics (CFG) approach to identify and prioritize genes involved in schizophrenia, by gene-level integration of genome-wide association study data with other genetic and gene expression studies in humans and animal models. Using this polyevidence scoring and pathway analyses, we identify top genes (DISC1, TCF4, MBP, MOBP, NCAM1, NRCAM, NDUFV2, RAB18, as well as ADCYAP1, BDNF, CNR1, COMT, DRD2, DTNBP1, GAD1, GRIA1, GRIN2B, HTR2A, NRG1, RELN, SNAP-25, TNIK), brain development, myelination, cell adhesion, glutamate receptor signaling, G-protein-- coupled receptor signaling and cAMP-mediated signaling as key to pathophysiology and as targets for therapeutic intervention. Overall, the data are consistent with a model of disrupted connectivity in schizophrenia, resulting from the effects of neurodevelopmental environmental stress on a background of genetic vulnerability. In addition, we show how the top candidate genes identified by CFG can be used to generate a genetic risk prediction score (GRPS) to aid schizophrenia diagnostics, with predictive ability in independent cohorts. The GRPS also differentiates classic age of onset schizophrenia from early onset and late-onset disease. -
Viewed and Published Immediately Upon Acceptance Cited in Pubmed and Archived on Pubmed Central Yours — You Keep the Copyright
BMC Genomics BioMed Central Research article Open Access Differential gene expression in ADAM10 and mutant ADAM10 transgenic mice Claudia Prinzen1, Dietrich Trümbach2, Wolfgang Wurst2, Kristina Endres1, Rolf Postina1 and Falk Fahrenholz*1 Address: 1Johannes Gutenberg-University, Institute of Biochemistry, Mainz, Johann-Joachim-Becherweg 30, 55128 Mainz, Germany and 2Helmholtz Zentrum München – German Research Center for Environmental Health, Institute for Developmental Genetics, Ingolstädter Landstraße 1, 85764 Neuherberg, Germany Email: Claudia Prinzen - [email protected]; Dietrich Trümbach - [email protected]; Wolfgang Wurst - [email protected]; Kristina Endres - [email protected]; Rolf Postina - [email protected]; Falk Fahrenholz* - [email protected] * Corresponding author Published: 5 February 2009 Received: 19 June 2008 Accepted: 5 February 2009 BMC Genomics 2009, 10:66 doi:10.1186/1471-2164-10-66 This article is available from: http://www.biomedcentral.com/1471-2164/10/66 © 2009 Prinzen et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Background: In a transgenic mouse model of Alzheimer disease (AD), cleavage of the amyloid precursor protein (APP) by the α-secretase ADAM10 prevented amyloid plaque formation, and alleviated cognitive deficits. Furthermore, ADAM10 overexpression increased the cortical synaptogenesis. These results suggest that upregulation of ADAM10 in the brain has beneficial effects on AD pathology. Results: To assess the influence of ADAM10 on the gene expression profile in the brain, we performed a microarray analysis using RNA isolated from brains of five months old mice overexpressing either the α-secretase ADAM10, or a dominant-negative mutant (dn) of this enzyme. -
Dixdc1 Is a Critical Regulator of DISC1 and Embryonic Cortical Development
Dixdc1 Is a Critical Regulator of DISC1 and Embryonic Cortical Development The MIT Faculty has made this article openly available. Please share how this access benefits you. Your story matters. Citation Singh, Karun K., Xuecai Ge, Yingwei Mao, Laurel Drane, Konstantinos Meletis, Benjamin A. Samuels, and Li-Huei Tsai. “Dixdc1 Is a Critical Regulator of DISC1 and Embryonic Cortical Development.” Neuron 67, no. 1 (July 15, 2010): 33–48. © 2010 Elsevier Inc. As Published http://dx.doi.org/10.1016/j.neuron.2010.06.002 Publisher Elsevier Version Final published version Citable link http://hdl.handle.net/1721.1/96067 Terms of Use Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use. Neuron Article Dixdc1 Is a Critical Regulator of DISC1 and Embryonic Cortical Development Karun K. Singh,1,2,3 Xuecai Ge,1,2 Yingwei Mao,1,2,3 Laurel Drane,1,2,3 Konstantinos Meletis,1,2,3 Benjamin A. Samuels,1,2,4 and Li-Huei Tsai1,2,3,* 1Howard Hughes Medical Institute 2Picower Institute for Learning and Memory, Department of Brain and Cognitive Sciences Massachusetts Institute of Technology, Cambridge, MA 02139, USA 3Stanley Center for Psychiatric Research, Broad Institute, Cambridge, MA 02139, USA 4Department of Psychiatry and Neuroscience, Columbia University, New York, NY 10032, USA *Correspondence: [email protected] DOI 10.1016/j.neuron.2010.06.002 SUMMARY mechanisms by which it contributes to risk for psychiatric disor- ders. Studies have demonstrated that DISC1 regulates embry- The psychiatric illness risk gene Disrupted in Schizo- onic neurogenesis, neuronal migration, axon differentiation, phrenia-1 (DISC1) plays an important role in brain and synapse formation, while in the adult brain, DISC1 modu- development; however, it is unclear how DISC1 is lates the genesis and circuit integration of new neurons (Brad- regulated during cortical development. -
DISC1-Binding Proteins in Neural Development, Signalling and Schizophrenia
Edinburgh Research Explorer DISC1-binding proteins in neural development, signalling and schizophrenia Citation for published version: Bradshaw, NJ & Porteous, DJ 2012, 'DISC1-binding proteins in neural development, signalling and schizophrenia', Neuropharmacology, vol. 62, no. 3, pp. 1230-41. https://doi.org/10.1016/j.neuropharm.2010.12.027 Digital Object Identifier (DOI): 10.1016/j.neuropharm.2010.12.027 Link: Link to publication record in Edinburgh Research Explorer Document Version: Publisher's PDF, also known as Version of record Published In: Neuropharmacology Publisher Rights Statement: Available under Open Access General rights Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s) and / or other copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated with these rights. Take down policy The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer content complies with UK legislation. If you believe that the public display of this file breaches copyright please contact [email protected] providing details, and we will remove access to the work immediately and investigate your claim. Download date: 25. Sep. 2021 Neuropharmacology 62 (2012) 1230e1241 Contents lists available at ScienceDirect Neuropharmacology journal homepage: www.elsevier.com/locate/neuropharm DISC1-binding proteins in neural development, signalling and schizophrenia Nicholas J. Bradshaw*, David J. Porteous Medical Genetics Section, Molecular Medicine Centre, Institute of Genetics & Molecular Medicine, University of Edinburgh, Western General Hospital, Crewe Road South, Edinburgh, Midlothian EH4 2XU, UK article info abstract Article history: In the decade since Disrupted in Schizophrenia 1 (DISC1)wasfirst identified it has become one of the most Received 29 October 2010 convincing risk genes for major mental illness. -
Structural and Functional Analysis of Translocation in DISC1 Gene and Impact on Schizophrenia
CAPITAL UNIVERSITY OF SCIENCE AND TECHNOLOGY, ISLAMABAD Structural and Functional Analysis of Translocation in DISC1 gene and Impact on Schizophrenia by Jaweria Zia A thesis submitted in partial fulfillment for the degree of Master of Science in the Faculty of Health and Life Sciences Department of Bioinformatics and Biosciences 2021 i Copyright © 2021 by Jaweria Zia All rights reserved. No part of this thesis may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, by any information storage and retrieval system without the prior written permission of the author. ii I dedicate this thesis to my parents and my teachers. CERTIFICATE OF APPROVAL Structural and Functional Analysis of Translocation in DISC1 gene and Impact on Schizophrenia by Jaweria Zia (MBS191024) THESIS EXAMINING COMMITTEE S. No. Examiner Name Organization (a) External Examiner Dr. Mazhar Qayyam PMAS-UAAR, Rawalpindi (b) Internal Examiner Dr. Erum Dilshad CUST, Islamabad (c) Supervisor Dr. Syeda Marriam Bakhtiar CUST, Islamabad Dr. Syeda Marriam Bakhtiar Thesis Supervisor April, 2021 Dr. Sahar Fazal Dr. Muhammad Abdul Qadir Head Dean Dept. of Biosciences & Bioinformatics Faculty of Health & Life Sciences April, 2021 April, 2021 iv Author's Declaration I, Jaweria Zia hereby state that my MS thesis titled \Structural and Func- tional Analysis of Translocation in DISC1 gene and Impact on Schizophre- nia" is my own work and has not been submitted previously by me for taking any degree from Capital University of Science and Technology, Islamabad or anywhere else in the country/abroad. At any time if my statement is found to be incorrect even after my graduation, the University has the right to withdraw my MS Degree. -
Abnormalities Induced by a Disc1 Mutation Modelling a Translocation Linked to Major Mental Illness Elise L
Malavasi et al. Translational Psychiatry (2018) 8:184 DOI 10.1038/s41398-018-0228-1 Translational Psychiatry ARTICLE Open Access DISC1 regulates N-methyl-D-aspartate receptor dynamics: abnormalities induced by a Disc1 mutation modelling a translocation linked to major mental illness Elise L. V. Malavasi1,KyriakosD.Economides2, Ellen Grünewald1, Paraskevi Makedonopoulou1, Philippe Gautier3, Shaun Mackie1, Laura C. Murphy1,HannahMurdoch4,DarraghCrummie1, Fumiaki Ogawa1,DanielL.McCartney1, Shane T. O’Sullivan1,KarenBurr5, Helen S. Torrance1, Jonathan Phillips1, Marion Bonneau1,SusanM.Anderson1, Paul Perry3, Matthew Pearson3, Costas Constantinides1, Hazel Davidson-Smith1, Mostafa Kabiri6, Barbara Duff7, Mandy Johnstone 1,7,H.GregPolites8,StephenM.Lawrie 7, Douglas H. Blackwood 7, Colin A. Semple3, Kathryn L. Evans1, Michel Didier9, Siddharthan Chandran5,AndrewM.McIntosh 7, David J. Price10,MilesD.Houslay11, David J. Porteous 1 and J. Kirsty Millar1 Abstract The neuromodulatory gene DISC1 is disrupted by a t(1;11) translocation that is highly penetrant for schizophrenia and affective disorders, but how this translocation affects DISC1 function is incompletely understood. N-methyl-D-aspartate receptors (NMDAR) play a central role in synaptic plasticity and cognition, and are implicated in the pathophysiology 1234567890():,; 1234567890():,; 1234567890():,; 1234567890():,; of schizophrenia through genetic and functional studies. We show that the NMDAR subunit GluN2B complexes with DISC1-associated trafficking factor TRAK1, while DISC1 interacts with the GluN1 subunit and regulates dendritic NMDAR motility in cultured mouse neurons. Moreover, in the first mutant mouse that models DISC1 disruption by the translocation, the pool of NMDAR transport vesicles and surface/synaptic NMDAR expression are increased. Since NMDAR cell surface/synaptic expression is tightly regulated to ensure correct function, these changes in the mutant mouse are likely to affect NMDAR signalling and synaptic plasticity. -
Deletion of Densin-180 Results in Abnormal Behaviors Associated with Mental Illness and Reduces Mglur5 and DISC1 in the Postsynaptic Density Fraction
16194 • The Journal of Neuroscience, November 9, 2011 • 31(45):16194–16207 Cellular/Molecular Deletion of Densin-180 Results in Abnormal Behaviors Associated with Mental Illness and Reduces mGluR5 and DISC1 in the Postsynaptic Density Fraction Holly J. Carlisle,1* Tinh N. Luong,1* Andrew Medina-Marino,1* Leslie Schenker,1 Eugenia Khorosheva,1 Tim Indersmitten,2 Keith M. Gunapala,1 Andrew D. Steele,1 Thomas J. O’Dell,2 Paul H. Patterson,1 and Mary B. Kennedy1 1Division of Biology, California Institute of Technology, Pasadena, California 91105, and 2 David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California 90095 Densin is an abundant scaffold protein in the postsynaptic density (PSD) that forms a high-affinity complex with ␣CaMKII and ␣-actinin. To assess the function of densin, we created a mouse line with a null mutation in the gene encoding it (LRRC7). Homozygous knock-out mice display a wide variety of abnormal behaviors that are often considered endophenotypes of schizophrenia and autism spectrum disorders. At the cellular level, loss of densin results in reduced levels of ␣-actinin in the brain and selective reduction in the localization of mGluR5 and DISC1 in the PSD fraction, whereas the amounts of ionotropic glutamate receptors and other prominent PSD proteins are unchanged. In addition, deletion of densin results in impairment of mGluR- and NMDA receptor-dependent forms of long-term depres- sion, alters the early dynamics of regulation of CaMKII by NMDA-type glutamate receptors, and produces a change in spine morphology. These results indicate that densin influences the function of mGluRs and CaMKII at synapses and contributes to localization of mGluR5 and DISC1 in the PSD fraction. -
DISC1 As a Genetic Risk Factor for Schizophrenia and Related Major Mental Illness: Response to Sullivan
Molecular Psychiatry (2014) 19, 141–143 © 2014 Macmillan Publishers Limited All rights reserved 1359-4184/14 www.nature.com/mp GUEST EDITORIAL DISC1 as a genetic risk factor for schizophrenia and related major mental illness: response to Sullivan Molecular Psychiatry (2014) 19, 141–143; doi:10.1038/mp.2013.160 t(1;11); the t(1;11) shows unequivocal linkage to the high burden of major mental illness in this family, and the t(1;11) has been scored both by classical chromosome banding and by fluores- cence in situ hybridisation16. The molecular cloning of the t(1;11) breakpoint4 with sequence confirmation has more recently In a recent guest editorial,1 Patrick Sullivan questioned several allowed us to develop a PCR-based assay spanning the break- aspects of the original Scottish t(1;11) family in which the DISC1 point; we routinely apply this test to validate samples in gene was discovered.2–4 He challenged the wider significance of contemporary studies (Thomson, unpublished). Finally, regarding the original genetic finding and questioned the relevance of DISC1 the Scottish t(1;11) pedigree, a major third wave of follow-up has biology to psychiatry, casting doubt on the validity of the recently been completed with brain imaging added to the clinical ‘integrative’ approach. Sullivan prefaced his strong views on phenotype: this will be submitted shortly for publication. DISC1 by welcoming the ‘uncompromising statistical rigour and Sullivan finds the spectrum of psychiatric diagnoses seen in the replication’ that is now being applied to his area of expertise in t(1;11) family ‘worrying’, but what the t(1;11) family showed par genome-wide association studies (GWAS). -
Supplementary Tables S1-S3
Supplementary Table S1: Real time RT-PCR primers COX-2 Forward 5’- CCACTTCAAGGGAGTCTGGA -3’ Reverse 5’- AAGGGCCCTGGTGTAGTAGG -3’ Wnt5a Forward 5’- TGAATAACCCTGTTCAGATGTCA -3’ Reverse 5’- TGTACTGCATGTGGTCCTGA -3’ Spp1 Forward 5'- GACCCATCTCAGAAGCAGAA -3' Reverse 5'- TTCGTCAGATTCATCCGAGT -3' CUGBP2 Forward 5’- ATGCAACAGCTCAACACTGC -3’ Reverse 5’- CAGCGTTGCCAGATTCTGTA -3’ Supplementary Table S2: Genes synergistically regulated by oncogenic Ras and TGF-β AU-rich probe_id Gene Name Gene Symbol element Fold change RasV12 + TGF-β RasV12 TGF-β 1368519_at serine (or cysteine) peptidase inhibitor, clade E, member 1 Serpine1 ARE 42.22 5.53 75.28 1373000_at sushi-repeat-containing protein, X-linked 2 (predicted) Srpx2 19.24 25.59 73.63 1383486_at Transcribed locus --- ARE 5.93 27.94 52.85 1367581_a_at secreted phosphoprotein 1 Spp1 2.46 19.28 49.76 1368359_a_at VGF nerve growth factor inducible Vgf 3.11 4.61 48.10 1392618_at Transcribed locus --- ARE 3.48 24.30 45.76 1398302_at prolactin-like protein F Prlpf ARE 1.39 3.29 45.23 1392264_s_at serine (or cysteine) peptidase inhibitor, clade E, member 1 Serpine1 ARE 24.92 3.67 40.09 1391022_at laminin, beta 3 Lamb3 2.13 3.31 38.15 1384605_at Transcribed locus --- 2.94 14.57 37.91 1367973_at chemokine (C-C motif) ligand 2 Ccl2 ARE 5.47 17.28 37.90 1369249_at progressive ankylosis homolog (mouse) Ank ARE 3.12 8.33 33.58 1398479_at ryanodine receptor 3 Ryr3 ARE 1.42 9.28 29.65 1371194_at tumor necrosis factor alpha induced protein 6 Tnfaip6 ARE 2.95 7.90 29.24 1386344_at Progressive ankylosis homolog (mouse)